Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
xebecinc.com/news/xebec-announces-q4-... MONTREAL (QC), March 25, 2021 – Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of clean energy solutions, announced today its 2020 fourth quarter and full year results, with the following highlights: Revenues increased by $7.2 million to $56.5 million for the twelve-month period ended December 31, 2020, compared to $49.3 million for the same period the prior year. Adjusted EBITDA of ($22.0) million for the twelve-month period ended December 31, 2020, compared to $7.0 million for the same period last year. Net loss of $32.0 million or ($0.33) per share compared to $2.0 million or $0.03 per share in the twelve-month period ended December 31, 2020 compared to the same period in the prior year. Working capital increased to $171.2 million on December 31, 2020, for a current ratio of 4.1:1, from working capital of $37.3 million and a current ratio of 3.2:1 on December 31, 2019. Management guidance for fiscal 2021 of consolidated revenues in the range of $110.0 to $130.0 million and an adjusted EBITDA margin in the range of 3.0% to 4.0%. As at December 31, 2020, the company had $168.6 million of cash compared to $22.7 million as at December 31, 2019. Financial Results Revenues decreased by $7.2 million to $6.4 million for the three-month period ended December 31, 2020, compared to $13.6 million for the same period the prior year. The decrease is mainly due to revenue adjustments in the last quarter due to extraordinary items in the Cleantech Systems business segment resulting from the impact of the COVID-19 pandemic and other operational issues, which substantially increased product, operational and installation costs. With the impact of COVID-19 lasting longer than expected and additional restrictions being re-imposed by local authorities in Q4/20, Xebec undertook a detailed accounting review of its long-term, production-type contracts for its renewable natural gas projects where revenues are recognized based on the percentage of completion method. As a result of the projected total cost of fulfilling these contracts having increased substantially, Xebec determined that previously incurred expenses represent a lower percentage of total costs than previously estimated. As such, revenues recognized to date had to be adjusted ($5.2 million) to reflect the revised percentage of completion for contracts under Xebec’s updated estimates. Furthermore, Xebec reversed revenues ($1.9 million) previously recognized based on the percentage of completion method due to the deteriorating financial position of a client where the likelihood of payment became uncertain in early 2021. Finally, two contracts that had become unprofitable were cancelled by a customer in early 2021 as a result of the delivery delays, due to COVID-19 and other related disruptions. This impact led to a $5.4 million revenue adjustment. The parts and materials used for these contracts have since been inventoried and are expected to be used for future contracts. Gross margin decreased from $4.1 million to ($11.4) million for the three-month period ended December 31, 2020 compared to the same period the prior year. The gross margin % decrease from 30% to (178%) is mainly due to the reversal of revenues described earlier and some of the contracts previously estimated to be profitable now projected to result in losses. The percentage of completion method requires that losses on such contracts be recognized immediately, further impacting the Company’s gross margin. Moreover, the impact of COVID-19 increased costs for projects in Italy and China, which also resulted in a gross margin deterioration. Selling and administrative expenses (“SG&A”) for the three-month period ended December 31, 2020, of $13.6 million were higher by $10.0 million compared to $3.6 million for the same three months of 2019. This is primarily due to several expenses that are non-recurring in nature that have been accounted for in the fourth quarter of 2020: (1) $4.8 million of transaction costs for the HyGear and Inmatec acquisitions; and (2) a $1.1 million provision for bad debt relating to uncollectible accounts receivable and a penalty for a biogas project in Europe. Additionally, $0.7 million of recurring administrative expenses resulted from the acquisitions of Titus and ACS. Finally, overall SG&A expenses increased due to an organizational scale up of employees and associated costs to support the increased level of sales, and from grants of restricted and deferred share units made to key employees. Net loss of $28.3 million or ($0.26) per share in the three-month period ended December 31, 2020 compared to a net loss of $0.5 million or ($0.01) per share for the same period the prior year. Adjusted EBITDA decreased to ($22.6) million for the three-month period ended December 31, 2020, from $2.1 million for the same period last year. Backlog increased by $0.8 million over the last 12 months, from $99.3 million on April 14, 2020 to $100.1 million on March 18, 2021. Recent Events On March 16, 2021, Xebec commented on class action lawsuit application filed in Québec On March 15, 2021, Xebec partnered with Coregas, one of Australia’s largest gas companies, to accelerate the development of hydrogen ecosystems in Australia and New Zealand On February 24, 2021, Xebec secured $59.3 million in new credit facilities from National Bank of Canada On February 22, 2021, Xebec completed its acquisition of Inmatec On February 16, 2021, Xebec launched UK hydrogen supply strategy with 15-year Gas-as-a-Service contract and construction of first Hydrogen Decentralized Production Hub in the country On February 11, 2021, Xebec received an order for FuelCell Energy’s Port of Long Beach Project with Toyota On January 7, 2021, Xebec graduated to the TSX and started trading on the exchange On December 31, 2020, Xebec completed its transformative acquisition of HyGear, a leading provider of local hydrogen through steam methane reforming and electrolysis On December 30, 2020, Xebec closed its $143.8 million bought deal public offering and $63.3 million concurrent private placement with CDPQ On December 17, 2020, Xebec entered the hydrogen and renewable natural gas markets in Germany with the acquisition of Inmatec, a world leader in on-site oxygen and nitrogen generation products On December 8, 2020, Xebec launched its hydrogen strategy with the transformative acquisition of HyGear On November 12, 2020, Xebec strengthened its partnership with Shenergy in China with a strategic investment
nine_inch_nerd schreef op 22 maart 2021 16:01 :
[...]
Idem. Same thought. Afgelopen weekend een order ingelegd en vanmiddag geactiveerd. Kleine hap weer en volgen.
Er wordt niet echt lekker gereageerd op de cijfers, terwijl de outlook voor 2021 er wel behoorlijk uitziet. Zelf koop ik denk ik nog niet bij, maar als het verder daalt overweeg ik het wel.
Was wel even slikken, die boekhoudkundige correcties...eenmalige correcties. De lijken zijn uit de kast?! De goede toekomstverwachtingen zijn in tact gebleven.
Ik heb bijgekocht tot mijn basisbedrag per fonds wat ik altijd investeer. Nu wachten!
nine_inch_nerd schreef op 31 maart 2021 11:32 :
Ik heb bijgekocht tot mijn basisbedrag per fonds wat ik altijd investeer. Nu wachten!
...de koers zal met horten en stoten omhoog gaan. Er is best wat pijn geleden, sommige van deze beleggers stappen straks uit bij een stijging, daarnaast heb je de goedkoopjes-beleggers die voor korte termijn Xebec hebben aangeschaft. Maar uiteindelijk... ;-)
Vitavita schreef op 31 maart 2021 16:19 :
[...]
...de koers zal met horten en stoten omhoog gaan.
Er is best wat pijn geleden, sommige van deze beleggers stappen straks uit bij een stijging, daarnaast heb je de goedkoopjes-beleggers die voor korte termijn Xebec hebben aangeschaft.
Maar uiteindelijk... ;-)
Over een maand krijgen de Hygear aandeelhouders hun stukken, benieuwd wat dat voor dynamiek met zich meebrengt. Ik verwacht eigenlijk geen grote verkopen, de overnamekoers van toen was CAD 6,03 en de hoogste koers CAD 11,55.
Did you know that you can generate worry-free income with biogas upgrading? Learn more about our BGX Biostream™. www.youtube.com/watch?v=esDxcn7cpX4
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
Nextensa
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee